| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
RNS News Service
I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.
Director/PDMR Shareholding
RNS
|
RNS Number : 3979D
Clinigen Group plc
28 October 2020
28 October 2020
Purchase of shares and PDMR notification
Clinigen Group plc
(AIM: CLIN, "Clinigen" or the "Company"), announces that, on 27 October 2020, four Board directors and a person closely associated with a director acquired ordinary shares in the Group as follows:
|
Name, title
|
Number of shares purchased
|
Per Share Price
purchased
|
Aggregated total
|
|
Peter Allen, Chairman
|
5,000
|
609.00p
|
£30,450
|
|
Ian Nicholson, NED
|
2,000
|
603.52p
|
£12,070
|
|
Anne Hyland, NED
|
7,716
|
606.98p
|
£46,835
|
|
Alan Boyd, NED
|
7,000
|
607.24p
|
£42,507
|
|
Catherine Nicholson
|
1,000
|
600.97p
|
£6,010
|
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.
-Ends-
Contact Details
|
Clinigen Group plc
|
Tel: +44 (0) 1283 495 010
|
|
Shaun Chilton, Group Chief Executive Officer
Nick Keher, Group Chief Financial Officer
|
|
|
|
|
|
J.P.Morgan Cazenove - Nominated Adviser & Joint Broker
|
Tel: +44 (0)20 7742 4000
|
|
James Mitford / Hemant Kapoor
|
|
|
|
|
|
RBC Capital Markets - Joint Broker
|
Tel: +44 (0)20 7653 4000
|
|
Marcus Jackson / Elliot Thomas
|
|
|
|
|
|
Instinctif Partners
Melanie Toyne Sewell / Phillip Marriage / Nathan Billis
|
Tel: +44 (0)20 7457 2020
Email: clinigen@instinctif.com
|
Notes to Editors
About Clinigen Group
Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combination of businesses focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. The Group has sites in North America, Europe, Africa and the Asia Pacific.
Clinigen now has over 1,150 employees across five continents in 14 countries, with supply and distribution hubs and operational centres of excellence in key long-term growth regions. The Group works with 21 of the top 25 pharmaceutical companies; interacting with over 18,000 registered users across over 115 countries, shipping approximately 6.5 million units in the year.
For more information on Clinigen, please visit
www.clinigengroup.com
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
|
a)
|
Name
|
Peter Allen
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chairman
|
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Clinigen Group plc
|
|
b)
|
Legal Entity Identifier
|
213800OBIKGI2JYYS227
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.1 pence each
GB00B89J2419
|
|
b)
|
Nature of the transaction
|
Purchase of shares
|
|
c)
|
Currency
|
GBP
|
|
d)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
609.00p per share
|
5,000 shares
|
|
|
|
e)
|
Aggregated information
- Aggregated volume
- Price
- Aggregated total
|
5,000 shares
609.00p
£30,450
|
|
f)
|
Date of the transaction
|
27 October 2020
|
|
g)
|
Place of the transaction
|
London Stock Exchange, AIM
|
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
|
a)
|
Name
|
Ian Nicholson
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non Executive Director
|
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Clinigen Group plc
|
|
b)
|
Legal Entity Identifier
|
213800OBIKGI2JYYS227
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.1 pence each
GB00B89J2419
|
|
b)
|
Nature of the transaction
|
Purchase of shares
|
|
c)
|
Currency
|
GBP
|
|
d)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
603.52p per share
|
2,000 shares
|
|
|
|
e)
|
Aggregated information
- Aggregated volume
- Price
- Aggregated total
|
2,000 shares
603.52p
£12,070
|
|
f)
|
Date of the transaction
|
27 October 2020
|
|
g)
|
Place of the transaction
|
London Stock Exchange, AIM
|
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
|
a)
|
Name
|
Catherine Nicholson
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Person closely associated with Ian Nicholson,
Non-Executive Director
|
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Clinigen Group plc
|
|
b)
|
Legal Entity Identifier
|
213800OBIKGI2JYYS227
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.1 pence each
GB00B89J2419
|
|
b)
|
Nature of the transaction
|
Purchase of shares
|
|
c)
|
Currency
|
GBP
|
|
d)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
600.97p per share
|
1,000 shares
|
|
|
|
e)
|
Aggregated information
- Aggregated volume
- Price
- Aggregated total
|
1,000 shares
600.97p
£6,010
|
|
f)
|
Date of the transaction
|
27 October 2020
|
|
g)
|
Place of the transaction
|
London Stock Exchange, AIM
|
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
|
a)
|
Name
|
Anne Hyland
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non Executive Director
|
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Clinigen Group plc
|
|
b)
|
Legal Entity Identifier
|
213800OBIKGI2JYYS227
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.1 pence each
GB00B89J2419
|
|
b)
|
Nature of the transaction
|
Purchase of shares
|
|
c)
|
Currency
|
GBP
|
|
d)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
607.00p per share
606.97p per share
|
3,858 shares
3,858 shares
|
|
|
|
e)
|
Aggregated information
- Aggregated volume
- Price
- Aggregated total
|
7,716 shares
606.98p
£46,835
|
|
f)
|
Date of the transaction
|
27 October 2020
|
|
g)
|
Place of the transaction
|
London Stock Exchange, AIM
|
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
|
a)
|
Name
|
Alan Boyd
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non Executive Director
|
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Clinigen Group plc
|
|
b)
|
Legal Entity Identifier
|
213800OBIKGI2JYYS227
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.1 pence each
GB00B89J2419
|
|
b)
|
Nature of the transaction
|
Purchase of shares
|
|
c)
|
Currency
|
GBP
|
|
d)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
607.24p per share
|
7,000 shares
|
|
|
|
e)
|
Aggregated information
- Aggregated volume
- Price
- Aggregated total
|
7,000 shares
607.24p
£42,507
|
|
f)
|
Date of the transaction
|
27 October 2020
|
|
g)
|
Place of the transaction
|
London Stock Exchange, AIM
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
DSHFLFITIALDFII
|
|
|
|
|
|
